Myostatin inhibition: A potential performance enhancement strategy?

Scandinavian Journal of Medicine and Science in Sports

Volumn 18, Issue 2, 2008, Pages 123-131

  Fedoruk, M N ^a   Rupert, J L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Doping in sports; Gene doping; Gene transfer techniques; Genetic enhancement; Muscle development; Myostatin

Indexed keywords

MYOSTATIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; ATHLETIC PERFORMANCE; DOPING; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MUSCLE ATROPHY; SKELETAL MUSCLE; SPORT;

ATHLETIC PERFORMANCE; DOPING IN SPORTS; HUMANS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; SPORTS; TRANSFORMING GROWTH FACTOR BETA;

EID: 41149131358     PISSN: 09057188     EISSN: 16000838     Source Type: Journal    
DOI: 10.1111/j.1600-0838.2007.00759.x     Document Type: Article

References (68)

1. Acosta J, Carpio Y, Borroto I, Gonzalez O, Estrada MP. Myostatin gene silenced by RNAi show a zebrafish giant phenotype. J Biotechnol 2005 : 119 : 324 331.
2. Adams AM, Pratt SL, Stice SL. Knockdown of the Dnmt1s transcript using small interfering RNA in primary murine and bovine fibroblast cells. Mol Reprod Dev 2005 : 72 : 311 319.
3. Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, Voit T, Muntoni F, Vrbova G, Partridge T, Zammit P, Bunger L, Patel K. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci USA 2007 : 104 : 1835 1840.
4. Azzazy HM, Mansour MM, Christenson RH. Doping in the recombinant era: strategies and counterstrategies. Clin Biochem 2005 : 38 : 959 965.
5. Baoutina A, Alexander IE, Rasko JE, Emslie KR. Potential use of gene transfer in athletic performance enhancement. Mol Ther 2007 : 15 : 1751 1766.
6. BBCNews. Drugs test denies Lazutina gold. 2002 (last accessed August 2007).
7. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002 : 420 : 418 421.
8. Braasch DA, Paroo Z, Constantinescu A, Ren G, Oz OK, Mason RP, Corey DR. Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorg Med Chem Lett 2004 : 14 : 1139 1143.
9. Brownlee C. Gene doping: will athletes go for the ultimate high? Science News On-line 2004 : 166 : 280.
10. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibe B, Bouix J, Caiment F, Elsen JM, Eychenne F, Larzul C, Laville E, Meish F, Milenkovic D, Tobin J, Charlier C, Georges M. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 2006 : 38 : 813 818.
11. Couzin J. Breakthrough of the year. Small RNAs make big splash. Science 2002 : 298 : 2296 2297.
12. Ferrell RE, Conte V, Lawrence EC, Roth SM, Hagberg JM, Hurley BF. Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes. Genomics 1999 : 62 : 203 207.
13. Ge G, Greenspan DS. Developmental roles of the BMP1/TLD metalloproteinases. Birth Defects Res C Embryo Today 2006 : 78 : 47 68.
14. Glover DJ, Lipps HJ, Jans DA. Towards safe, non-viral therapeutic gene expression in humans. Nat Rev Genet 2005 : 6 : 299 310.
15. Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K, Ezzat S, Shen R, Lalani R, Asa S, Mamita M, Nair G, Arver S, Bhasin S. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci USA 1998 : 95 : 14938 14943.
16. Gustin P, Bakima M, Art T, Lekeux P, Lomba F, van de Woestijne KP. Pulmonary function values and growth in Belgian white and blue double-muscled cattle. Res Vet Sci 1988a : 45 : 405 410.
17. Gustin P, Dhem AR, Lomba F, Lekeux P. Cardio-pulmonary function values in double-muscled cattle during muscular exercise. Vet Res Commun 1988b : 12 : 407 416.
18. Haisma HJ, de Hon O. Gene doping. Int J Sports Med 2006 : 27 : 257 266.
19. Holmes JH, Ashmore CR, Robinson DW. Effects of stress on cattle with hereditary muscular hypertrophy. J Anim Sci 1973 : 36 : 684 694.
20. Hooper R. Mighty mice hold key to muscle-wasting disease. NewScientist, 2005, (last accessed August 2007).
21. Iezzi S, Di Padova M, Serra C, Caretti G, Simone C, Maklan E, Minetti G, Zhao P, Hoffman EP, Puri PL, Sartorelli V. Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev Cell 2004 : 6 : 673 684.
22. Joulia-Ekaza D, Cabello G. Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects. Exp Cell Res 2006 : 312 : 2401 2414.
23. Judge AD, Bola G, Lee AC, MacLachlan I. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol Ther 2006 : 13 : 494 505.
24. Judge AD, Sood V, Shaw JR, Fang D, McClintock K, MacLachlan I. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 2005 : 23 : 457 462.
25. Kelly WK, O'Connor OA, Marks PA. Histone deacetylase inhibitors: from target to clinical trials. Expert Opin Investig Drugs 2002 : 11 : 1695 1713.
26. Lalani R, Bhasin S, Byhower F, Tarnuzzer R, Grant M, Shen R, Asa S, Ezzat S, Gonzalez-Cadavid NF. Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. J Endocrinol 2000 : 167 : 417 428.
27. Lee SJ. Quadrupling muscle mass in mice by Targeting TGF-ss signaling pathways. PLoS One 2007 : 2 : e789.
28. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 2001 : 98 : 9306 9311.
29. Lee SJ, Reed LA, Davies MV, Girgenrath S, Goad ME, Tomkinson KN, Wright JF, Barker C, Ehrmantraut G, Holmstrom J, Trowell B, Gertz B, Jiang MS, Sebald SM, Matzuk M, Li E, Liang LF, Quattlebaum E, Stotish RL, Wolfman NM. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci USA 2005 : 102 : 18117 18122.
30. Ma K, Mallidis C, Artaza J, Taylor W, Gonzalez-Cadavid N, Bhasin S. Characterization of 5′-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol Endocrinol Metab 2001 : 281 : E1128 E1136.
31. Magee TR, Artaza JN, Ferrini MG, Vernet D, Zuniga FI, Cantini L, Reisz-Porszasz S, Rajfer J, Gonzalez-Cadavid NF. Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass. J Gene Med 2006 : 8 : 1171 1181.
32. Marks PA, Richon VM, Kelly WK, Chiao JH, Miller T. Histone deacetylase inhibitors: development as cancer therapy. Novartis Found Symp 2004 : 259 : 269 281 discussion 281-268.
33. Matsakas A, Diel P. The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis. Int J Sports Med 2005 : 26 : 83 89.
34. Matzuk MM, Lu N, Vogel H, Sellheyer K, Roop DR, Bradley A. Multiple defects and perinatal death in mice deficient in follistatin. Nature 1995 : 374 : 360 363.
35. McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R. Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 2003 : 162 : 1135 1147.
36. McNally EM. Powerful genes - myostatin regulation of human muscle mass. N Engl J Med 2004 : 350 : 2642 2644.
37. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997 : 387 : 83 90.
38. McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 1997 : 94 : 12457 12461.
39. Miah A. Genetically modified athletes. London : Routledge, 2004.
40. Minetti GC, Colussi C, Adami R, Serra C, Mozzetta C, Parente V, Fortuni S, Straino S, Sampaolesi M, Di Padova M, Illi B, Gallinari P, Steinkuhler C, Capogrossi MC, Sartorelli V, Bottinelli R, Gaetano C, Puri PL. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med 2006 : 12 : 1147 1150.
41. Ramazanov Z, Jimenez del Rio M, Ziegenfuss T. Sulfated polysaccharides of brown seaweed Cystoseira canariensis bind to serum myostatin protein. Acta Physiol Pharmacol Bulg 2003 : 27 : 101 106.
42. Raue U, Slivka D, Jemiolo B, Hollon C, Trappe S. Myogenic gene expression at rest and after a bout of resistance exercise in young (18-30 yr) and old (80-89 yr) women. J Appl Physiol 2006 : 101 : 53 59.
43. Rehfeldt C, Ott G, Gerrard DE, Varga L, Schlote W, Williams JL, Renne U, Bunger L. Effects of the compact mutant myostatin allele Mstn (Cmpt-dl1Abc) introgressed into a high growth mouse line on skeletal muscle cellularity. J Muscle Res Cell Motility 2005 : 26 : 103 112.
44. Roth SM, Martel GF, Ferrell RE, Metter EJ, Hurley BF, Rogers MA. Myostatin gene expression is reduced in humans with heavy-resistance strength training: a brief communication. Exp Biol Med (Maywood) 2003 : 228 : 706 709.
45. Saunders MA, Good JM, Lawrence EC, Ferrell RE, Li WH, Nachman MW. Human adaptive evolution at Myostatin (GDF8), a regulator of muscle growth. Am J Hum Genet 2006 : 79 : 1089 1097.
46. Schneider AJ, Friedmann T. Gene doping in sports: the science and ethics of genetically modified athletes. Adv Genet 2006 : 51 : 1 110.
47. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004 : 350 : 2682 2688.
48. Seibert MJ, Xue QL, Fried LP, Walston JD. Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the women's health and aging study II cohort. J Am Geriatr Soc 2001 : 49 : 1093 1096.
49. Seifulla R, Abidoff M, Miguel Jimenez del Rio M, Ziegenfuss T, Krendal F. Extract of marine plant Cystoseira canariensis (Cystocan), supplemented with whey protein and creatine, enhance muscle creatine content and protein synthesis in healthy, sedentary males participating in a resistance-training program. 2005, (last accessed August 2007).
50. Siriett V, Salerno MS, Berry C, Nicholas G, Bower R, Kambadur R, Sharma M. Antagonism of myostatin enhances muscle regeneration during sarcopenia. Mol Ther 2007 : 15 : 1463 1470.
51. Slot O. Researchers scent blood on trail of new cheats. Times Online, 2006.
52. Sunada Y. Therapeutic strategies for muscular dystrophy by myostatin inhibition. Rinsho Shinkeigaku 2006 : 11 : 942 944 [in Japanese].
53. Sweeney HL. Gene doping. Sci Am 2004 : 291 : 62 69.
54. Tang L, Yan Z, Wan Y, Han W, Zhang Y. Myostatin DNA vaccine increases skeletal muscle mass and endurance in mice. Muscle Nerve 2007 : 36 : 342 348.
55. Tobin JF, Celeste AJ. Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases. Curr Opin Pharmacol 2005 : 5 : 328 332.
56. Tsuchida K. The role of myostatin and bone morphogenetic proteins in muscular disorders. Expert Opin Biol Ther 2006 : 6 : 147 154.
57. Unal M, Ozer Unal D. Gene doping in sports. Sports Med 2004 : 34 : 357 362.
58. Wagner KR. Muscle regeneration through myostatin inhibition. Curr Opin Rheumatol 2005 : 17 : 720 724.
59. Walsh S, Metter EJ, Ferrucci L, Roth SM. Activin RIIB and Follistatin haplotype associations with muscle mass and strength in humans. J Appl Physiol 2007 : 102 : 2142 2148.
60. Wegner J, Albrecht E, Fiedler I, Teuscher F, Papstein HJ, Ender K. Growth- and breed-related changes of muscle fiber characteristics in cattle. J Anim Sci 2000 : 78 : 1485 1496.
61. Welle S, Bhatt K, Pinkert CA, Tawil R, Thornton CA. Muscle growth after post-developmental myostatin gene knockout. Am J Physiol Endocrinol Metab 2007 : 292 : E985 E991.
62. Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A, Maylor R, O'Hara D, Pearson A, Quazi A, Ryerson S, Tan XY, Tomkinson KN, Veldman GM, Widom A, Wright JF, Wudyka S, Zhao L, Wolfman NM. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 2003 : 300 : 965 971.
63. Willoughby DS. Effects of an alleged myostatin-binding supplement and heavy resistance training on serum myostatin, muscle strength and mass, and body composition. Int J Sport Nutr Exerc Metab 2004 : 14 : 461 472.
64. Wolfman NM, McPherron AC, Pappano WN, Davies MV, Song K, Tomkinson KN, Wright JF, Zhao L, Sebald SM, Greenspan DS, Lee SJ. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci USA 2003 : 100 : 15842 15846.
65. Zachwieja JJ, Smith SR, Sinha-Hikim I, Gonzalez-Cadavid N, Bhasin S. Plasma myostatin-immunoreactive protein is increased after prolonged bed rest with low-dose T3 administration. J Gravit Physiol 1999 : 6 : 11 15.
66. Zhao B, Wall RJ, Yang J. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem Biophys Res Commun 2005 : 337 : 248 255.
67. Zhu X, Hadhazy M, Wehling M, Tidball JG, McNally EM. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett 2000 : 474 : 71 75.
68. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, Lee SJ. Induction of cachexia in mice by systemically administered myostatin. Science 2002 : 296 : 1486 1488.